Scilex
SCLX | NASDAQ
$1.25
-$0.18 (-12.59%)
At close: Nov 16, 2026, 4:00 PM ET
$1.25
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-12.59%
(1D)No price chart data available for 1D timeframe.
Rating
31.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #769/1021 (Top 75%)
Key Statistics
Market Data
Market Cap $8.79M
1D Range
1.24 1.39
52W Range
1.24 22.51
Valuation (TTM)
PE -0.02
PB -0.03
EV/EBITDA -0.29
Valuation (NTM)
Forward PE 4.07
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -203.8%
SBC Adj. FCF Yield -323.0%
SBC Impact -58.5%
Margins
Gross Margin 41.5%
Operating Margin -903.5%
FCF Margin -56.7%
Growth (CAGR)
Revenue 3Y | 5Y -12.1% |
3.6%
Dil EPS 3Y | 5Y -39.4% |
-50.2%
FCF 3Y | 5Y -319.2% |
82.8%
Returns
ROA -176.3%
ROE 189.8%
ROIC 162.6%
Financial Health
Net Debt
$94.98M
Current Ratio 0.07
Interest Coverage -17.65
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its prim...
Sector Healthcare
Industry Drug Manufacturers - General
Employees 34
IPO Date Mar 5, 2021
Website www.scilexholding.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SCLX